Tandem Diabetes Care (TNDM) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.54% |
| Dec 31, 2025 | 10.81% |
| Sep 30, 2025 | 9.58% |
| Jun 30, 2025 | 11.80% |
| Mar 31, 2025 | 16.06% |
| Dec 31, 2024 | 18.87% |
| Sep 30, 2024 | 23.63% |
| Jun 30, 2024 | 28.15% |
| Mar 31, 2024 | 35.17% |
| Dec 31, 2023 | 34.87% |
| Sep 30, 2023 | 33.93% |
| Jun 30, 2023 | 32.28% |
| Mar 31, 2023 | 31.65% |
| Dec 31, 2022 | 28.41% |
| Sep 30, 2022 | 29.16% |
| Jun 30, 2022 | 22.15% |
| Mar 31, 2022 | 19.02% |
| Dec 31, 2021 | 22.31% |
| Sep 30, 2021 | 23.36% |
| Jun 30, 2021 | 24.66% |
| Mar 31, 2021 | 25.91% |
| Dec 31, 2020 | 26.36% |
| Sep 30, 2020 | 27.07% |
| Jun 30, 2020 | 25.38% |
| Mar 31, 2020 | 23.82% |
| Dec 31, 2019 | 21.22% |
| Sep 30, 2019 | 17.86% |
| Jun 30, 2019 | 12.77% |
| Mar 31, 2019 | 9.70% |
| Dec 31, 2018 | 11.65% |